How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Emerging Mental Health Device and Platform Market
- By Device Type: Wearable Mental Health Devices, Neurostimulation Devices, Digital Therapeutics Platforms, Mobile Mental Health Apps, Biofeedback Devices
- By End User: Healthcare Providers, Individual Consumers, Employers and Corporations, Mental Health Clinics, Research Institutions
- By Technology: Cognitive Behavioral Therapy (CBT) Platforms, Artificial Intelligence-based Diagnostic Tools, Virtual Reality Therapy Systems, Electroencephalogram (EEG) Devices, Transcranial Magnetic Stimulation (TMS) Devices
- By Application: Depression Management, Anxiety Disorders, Stress Reduction, Sleep Disorders, Post-Traumatic Stress Disorder (PTSD)
- By Delivery Mode: Cloud-based Platforms, On-premise Solutions, Mobile Application-based, Integrated Device-Platform Systems
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Wearable Mental Health Devices leads By Device Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 303 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.184 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.192 →
Full report · locked preview
Everything inside the Emerging Mental Health Device and Platform Market report
A complete, evidence-based study - 12 chapters and 127 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Device Type 5
End User 5
Technology 5
Application 5
Delivery Mode 4
Companies profiled
Pear Therapeutics
Mindstrong Health
Headspace Health
Calm
Talkspace (now BetterHelp)
Ginger (part of Headspace Health)
Happify Health
Big Health
BioBeats
NeuroFlow
Spring Health
SilverCloud Health
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Pear Therapeutics
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Mindstrong Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Headspace Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Calm
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Talkspace (now BetterHelp)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Ginger (part of Headspace Health)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Happify Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Big Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →BioBeats
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →NeuroFlow
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Spring Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →SilverCloud Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Woebot Health
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Cerebral
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Meru Health
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,764M by 2033 · 7.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Wearable Mental Health Devices41.1
- Neurostimulation Devices15.5
- Digital Therapeutics Platforms13.3
- Mobile Mental Health Apps13.8
- Biofeedback Devices16.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$526.3M → $1,012M · 8.5%
Europe$366.8M → $652.4M · 7.5%
Asia Pacific$334.9M → $649.5M · 8.6%
Latin America$207.3M → $377.9M · 7.8%
Middle East and Africa$159.5M → $255.9M · 6.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.072026
7.082027
7.102028
7.102029
7.122030
7.122031
7.142032
7.162033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Pear Therapeutics21.3
- Mindstrong Health17.9
- Headspace Health12.7
- Calm7.3
- Talkspace (now BetterHelp)7.3
- Ginger (part of Headspace Health)5.6
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Device Type18.2%
End User17.7%
Technology23.0%
Application23.2%
Delivery Mode18.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.3
- Europe22.1
- Asia Pacific22.0
- Latin America12.8
- Middle East and Africa8.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Pear Therapeutics | 97 | 91 | 90 | 84 | 95 | 87 | 91 |
| Mindstrong Health | 91 | 90 | 87 | 75 | 74 | 89 | 84 |
| Headspace Health | 86 | 81 | 76 | 68 | 86 | 80 | 80 |
| Calm | 75 | 57 | 72 | 71 | 61 | 73 | 68 |
| Talkspace (now BetterHelp) | 67 | 60 | 54 | 66 | 65 | 58 | 62 |
| Ginger (part of Headspace Health) | 57 | 46 | 62 | 57 | 55 | 49 | 54 |
| Happify Health | 41 | 61 | 64 | 47 | 49 | 66 | 55 |
| Big Health | 36 | 50 | 47 | 57 | 55 | 45 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Pear Therapeutics
- Mindstrong Health
- Headspace Health
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Pear Therapeutics | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Mindstrong Health | ✓ | ◐ | ✓ | ✓ | − | ✓ |
| Headspace Health | ◐ | ✓ | ✓ | ◐ | ◐ | ◐ |
| Calm | ✓ | ◐ | ◐ | ◐ | − | ◐ |
| Talkspace (now BetterHelp) | ◐ | ◐ | − | − | ◐ | ◐ |
| Ginger (part of Headspace Health) | ◐ | − | − | ◐ | ◐ | − |
| Happify Health | − | − | ◐ | − | − | ✓ |
| Big Health | − | − | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Pear Therapeutics91
2Mindstrong Health84
3Headspace Health80
4Calm68
5Talkspace (now BetterHelp)62
6Happify Health55
7Ginger (part of Headspace Health)54
8Big Health48
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Pear TherapeuticsMindstrong HealthHeadspace Health
Challenger1
Strong scale, closing on the leaders.
Calm
Contender1
Focused players with pockets of strength.
Talkspace (now BetterHelp)
Niche3
Specialists in a single segment or region.
Ginger (part of Headspace Health)Happify HealthBig Health
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Device Type in North America, then scale across Emerging Mental Health Device and Platform Market — a $204M beachhead inside a $3.06B market.
Beachhead (SOM)$204Mobtainable near-term
Serviceable (SAM)$1.23Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Wearable Mental Health Devices
Best fit — highest urgency & budget in Device Type.
Economic buyer79 fit
Neurostimulation Devices
Strong fit — clear ROI and a fast path to value.
End user69 fit
Digital Therapeutics Platforms
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Device Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Technology
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales41%
Partner / channel28%
Digital / self-serve23%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Device Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Emerging Mental Health Device and Platform Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified46%
Sales qualified22%
Evaluation12%
Closed-won8%
$18.2KCAC
$82KLTV
4.5:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Emerging Mental Health Device and Platform Market is a resilient opportunity — $3.32B by 2033, compounding at 5.3%.
TAM · 2025$2.20Btoday
TAM · 2033$3.32Bforecast
CAGR5.3%2027–2033
Cumulative$24.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.32BTotal addressable market
SAM$1.15BServiceable available market
SOM$186MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.3% CAGR
Demand compounds through 2033, outpacing GDP across Device Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Device Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.32BLarge & growingTAM by 2033 at 5.3% CAGR
$1.15BServiceable nowreachable with today’s model
$186MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.59BBear3.4% CAGR
$3.32BBase5.3% CAGR
$4.24BBull7.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Emerging Mental Health Device and Platform Market — a $4.43B market by 2033. Plan: grow share from 7.8% to 16.5%.
Market size · 2033$4.43Btotal addressable
Market CAGR10.3%2027–2033
Target share16.5%from 7.8% today
Revenue ambition$732Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.8% | 16.5% | On track |
| Revenue | $337M | $732M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 32.5% | 41.4% | On track |
| Customer retention | 85.0% | 94.6% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Device Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Device Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $103M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Device Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Emerging Mental Health Device and Platform Market conversation — a $5.23B market you can size, segment and defend in minutes.
Market size · 2033$5.23Btotal opportunity
Growth8.7%CAGR to 2033
Addressable buyers1,385+accounts in scope
Typical ROI7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Device Type
Goal Grow share in Device Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7×return on cost, year one
< 4 mopayback period
$44K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Pear TherapeuticsMindstrong HealthHeadspace HealthCalmTalkspace (now BetterHelp)Ginger (part of Headspace Health)Happify HealthBig Health+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Emerging Mental Health Device and Platform Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Emerging Mental Health Device and Platform Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →2-Carboxyethyl Phenyl Phosphinic Acid(CEPPA) Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportEmerging Infectious Disease Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View report2,6-Difluorobenzyl Bromide Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportEmergency Vacuum Splint & Mattress Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportEmergency Vacuum Splint Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportEmergency Trolley Market
Market size, share, segmentation and regional forecast.
$356M market · 2025 base year
View reportPropofol Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportEmergency Trauma Dressing Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportEmergency Transport Ventilators Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportEmergency Transport Ventilators and Monitors Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportEmergency Transfer Equipment Market
Market size, share, segmentation and regional forecast.
$607M market · 2025 base year
View reportEmergency Traction Splint Market
Market size, share, segmentation and regional forecast.
$718M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.